Type |
Details |
Score |
HT Experiment |
Series Id: |
GSE42603 |
Experiment Type: |
transcription profiling by array |
Study Type: |
WT vs. Mutant |
Source: |
ArrayExpress |
|
•
•
•
•
•
|
Publication |
First Author: |
Kaufmann D |
Year: |
1999 |
Journal: |
DNA Cell Biol |
Title: |
EVI2B, a gene lying in an intron of the neurofibromatosis type 1 (NF1) gene, is as the NF1 gene involved in differentiation of melanocytes and keratinocytes and is overexpressed in cells derived from NF1 neurofibromas. |
Volume: |
18 |
Issue: |
5 |
Pages: |
345-56 |
|
•
•
•
•
•
|
Allele |
Name: |
neurofibromin 1; targeted mutation 1, Luis F Parada |
Allele Type: |
Targeted |
Attribute String: |
Conditional ready, No functional change |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Nf1/Nf1<+> |
Background: |
involves: 129S2/SvPas * C57BL/6 |
Zygosity: |
ht |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Nf1/Nf1 |
Background: |
involves: 129S1/Sv * C57BL/6 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Nf1/Nf1 Tg(Syn1-cre)671Jxm/? |
Background: |
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Nf1/Nf1<+> |
Background: |
involves: 129S2/SvPas * C57BL/6J |
Zygosity: |
ht |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Grin1/Grin1<+> Nf1/Nf1<+> |
Background: |
involves: 129S2/SvPas * C57BL/6J |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Nf1/Nf1<+> Trp53/Trp53<+> |
Background: |
involves: 129/Sv * C57BL/6 |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Nf1/Nf1 Tg(Mpz-cre)94Imeg/? |
Background: |
involves: 129S1/Sv * 129X1/SvJ |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Nf1/Nf1 Tg(Pax3-cre)1Joe/? |
Background: |
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Nf1/Nf1 H2az2/H2az2<+> |
Background: |
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Nf1/Nf1 Tg(Fabp7-cre,-lacZ)3Gtm/? |
Background: |
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Kras/Kras<+> Pten/Pten<+> Tg(Gfap-cre)77.6Mvs/? |
Background: |
involves: 129S4/SvJae * BALB/c * C57BL/6NHsd |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Nf1/Nf1 Tg(Prrx1-cre)1Cjt/? |
Background: |
involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL/J |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Nf1/Nf1 Tg(Prrx1-cre)1Cjt/? |
Background: |
involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * C57BL/6N * SJL/J |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Nf1/Nf1 Tg(Dhh-cre)1Mejr/? |
Background: |
involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6N * C57BL/6NTac * FVB/N |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Nf1/Nf1 Tg(Dhh-cre)1Mejr/? |
Background: |
involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6N * FVB/N |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Nf1/Nf1<+> |
Background: |
involves: C3HeB/FeJ * C57BL/6 |
Zygosity: |
ht |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Muller WJ |
Year: |
1988 |
Journal: |
Cell |
Title: |
Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. |
Volume: |
54 |
Issue: |
1 |
Pages: |
105-15 |
|
•
•
•
•
•
|
HT Experiment |
Series Id: |
GSE29343 |
Experiment Type: |
transcription profiling by array |
Study Type: |
WT vs. Mutant |
Source: |
ArrayExpress |
|
•
•
•
•
•
|
Strain |
Attribute String: |
Not specified |
|
•
•
•
•
•
|
Strain |
Attribute String: |
mutant strain, targeted mutation |
|
•
•
•
•
•
|
Strain |
Attribute String: |
congenic, mutant strain, targeted mutation |
|
•
•
•
•
•
|
Strain |
Attribute String: |
targeted mutation, mutant strain |
|
•
•
•
•
•
|
Strain |
Attribute String: |
congenic, mutant strain, targeted mutation |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Nf1/Nf1 |
Background: |
involves: 129S/SvEv |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Nf1/Nf1 |
Background: |
involves: 129 * 129S/SvEv * C57BL/6 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Nf1/Nf1 |
Background: |
involves: 129 * 129S/SvEv * C3H * C57BL/6 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Nf1/Nf1<+> Trp53/Trp53 |
Background: |
involves: 129S/SvEv * 129S2/SvPas * C57BL/6 |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Nf1/Nf1<+> Tg(GFAP-cre)#Gtm/? |
Background: |
involves: 129S/SvEv * 129S4/SvJae * C57BL/6 * CBA |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Nf1/Nf1<+> Tg(Cnp-EGFR)10Nrat/? |
Background: |
involves: 129S/SvEv * C57BL/6 * SJL |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Reilly KM |
Year: |
2008 |
Journal: |
Cell |
Title: |
It takes a (dysfunctional) village to raise a tumor. |
Volume: |
135 |
Issue: |
3 |
Pages: |
408-10 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gutmann DH |
Year: |
2014 |
Journal: |
Cancer Cell |
Title: |
NF GEMMs already! The power and promise of mouse tumor models. |
Volume: |
26 |
Issue: |
5 |
Pages: |
596-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wulf G |
Year: |
2004 |
Journal: |
EMBO J |
Title: |
Modeling breast cancer in vivo and ex vivo reveals an essential role of Pin1 in tumorigenesis. |
Volume: |
23 |
Issue: |
16 |
Pages: |
3397-407 |
|
•
•
•
•
•
|
Strain |
Attribute String: |
mutant strain, targeted mutation, congenic |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Nf1/Nf1 |
Background: |
involves: 129S/SvEv * 129S1/Sv * 129S2/SvPas * 129X1/SvJ |
Zygosity: |
ht |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Hprt1/Hprt1<+> Nf1/Nf1 |
Background: |
involves: 129S/SvEv * 129S/SvEvBrd |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Gt(ROSA)26Sor/Gt(ROSA)26Sor Hprt1/Hprt1<+> Nf1/Nf1 |
Background: |
involves: 129S/SvEv * 129S/SvEvBrd |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Nf1/Nf1 Pax3/Pax3<+> |
Background: |
involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Nf1/Nf1<+> Tsc1/Tsc1 Tg(GFAP-cre)#Gtm/? |
Background: |
involves: 129S/SvEv * 129S4/SvJae * C57BL/6 * CBA |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Nf1/Nf1<+> Trp53/Trp53<+> |
Background: |
B6.129-Trp53 Nf1 |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Xu WM |
Year: |
1991 |
Journal: |
Genomics |
Title: |
The gene for von Recklinghausen neurofibromatosis (NF1) maps to the pericentromeric region of chromosome 17 in Chinese families. |
Volume: |
10 |
Issue: |
4 |
Pages: |
1090-2 |
|
•
•
•
•
•
|
Publication |
First Author: |
Osada S |
Year: |
1999 |
Journal: |
Biochem J |
Title: |
Expression, DNA-binding specificity and transcriptional regulation of nuclear factor 1 family proteins from rat. |
Volume: |
342 ( Pt 1) |
|
Pages: |
189-98 |
|
•
•
•
•
•
|
Publication |
First Author: |
Fukuda A |
Year: |
2003 |
Journal: |
J Biol Chem |
Title: |
Alleviation of PC4-mediated transcriptional repression by the ERCC3 helicase activity of general transcription factor TFIIH. |
Volume: |
278 |
Issue: |
17 |
Pages: |
14827-31 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Homologous_superfamily |
Description: |
This superfamily represents a ssDNA-binding transcriptional regulator domain consisting of a helix-swapped dimer of beta(4)-alpha motifs. This domain is found as a C-terminal domain in the transcriptional co-activator PC4 (also known as P15; where it is a dimer of two separate motifs), and in the plant transcriptional regulator PBF-2 (where it is a single chain domain formed by a tandem repeat of two motifs).Transcriptional regulators play a critical role in controlling the level of transcription from specific genes in response to different stimuli. Members of this family of transcriptional regulators, which preferentially bind single-stranded DNA, include PBF-2 from plants, the mammalian nuclear factor 1-X (NF1-X), and positive cofactor 4 (PC4). These proteins are structurally similar, consisting of a helix-swapped dimer of beta(4)-alpha motifs.The plant defence transcription factor PBF-2 is comprised of four p24 subunits that interact through a helix-loop-helix motif to produce a central pore []. PBF-2 functions as part of the plant's defence system in response to the detection of a pathogen. Upon stimulation, PBF-2 induces several signal transduction pathways leading to changes in the expression of defence genes, including the pathogenesis-related (PR) genes.NF1-X is one of several NF1 proteins that function as transcription factors. NF1-X consists of two functionally distinct domains: a conserved N-terminal DNA-binding domain and a C-terminal transcriptional regulatory domain. NF1-X binds to the promoter for the 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase gene [].PC4 (or P15) possess the ability to co-activate and suppress transcription via its DNA-binding activity. PC4 has been shown to stimulate transcription in vitrowith diverse activators, including VP16, thyroid hormone receptor, BRCA-1, often involving TFIIA. PC4 and TFIIA are thought to facilitate the assembly of the pre-initiation complex. The repressive activity of PC4 can be alleviated by the transcription factor TFIIH, which protects promoters from PC4 repression []. PC4 consists of two domains: an N-terminal regulatory domain and a C-terminal cryptic DNA-binding domain. The protein acts as a dimer with two ssDNA binding channels running in opposite directions to each other []. |
|
•
•
•
•
•
|
Publication |
First Author: |
Kane R |
Year: |
2000 |
Journal: |
Adv Exp Med Biol |
Title: |
Transcription factor NF 1 expression in involuting mammary gland. |
Volume: |
480 |
|
Pages: |
117-22 |
|
•
•
•
•
•
|
Publication |
First Author: |
Parada LF |
Year: |
2005 |
Journal: |
Cold Spring Harb Symp Quant Biol |
Title: |
Modeling neurofibromatosis type 1 tumors in the mouse for therapeutic intervention. |
Volume: |
70 |
|
Pages: |
173-6 |
|
•
•
•
•
•
|
Publication |
First Author: |
Pong WW |
Year: |
2013 |
Journal: |
Ann Neurol |
Title: |
Reduced microglial CX3CR1 expression delays neurofibromatosis-1 glioma formation. |
Volume: |
73 |
Issue: |
2 |
Pages: |
303-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ratner N |
Year: |
2015 |
Journal: |
Nat Rev Cancer |
Title: |
A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor. |
Volume: |
15 |
Issue: |
5 |
Pages: |
290-301 |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Nf1/Nf1 Tg(Tek-cre)1Ywa/? |
Background: |
involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Nf1/Nf1 Tg(Tek-cre)1Ywa/? |
Background: |
involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Egfr/Egfr<+> Nf1/Nf1<+> Trp53/Trp53<+> |
Background: |
involves: 129S/SvEv * 129S7/SvEvBrd * C57BL/6 * C57BL/6JEi * C3H/HeSnJ |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Brandsen J |
Year: |
1997 |
Journal: |
Nat Struct Biol |
Title: |
C-terminal domain of transcription cofactor PC4 reveals dimeric ssDNA binding site. |
Volume: |
4 |
Issue: |
11 |
Pages: |
900-3 |
|
•
•
•
•
•
|
Publication |
First Author: |
Desveaux D |
Year: |
2002 |
Journal: |
Nat Struct Biol |
Title: |
A new family of plant transcription factors displays a novel ssDNA-binding surface. |
Volume: |
9 |
Issue: |
7 |
Pages: |
512-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chong JA |
Year: |
2005 |
Journal: |
Mol Cell Biol |
Title: |
TATA-binding protein (TBP)-like factor (TLF) is a functional regulator of transcription: reciprocal regulation of the neurofibromatosis type 1 and c-fos genes by TLF/TRF2 and TBP. |
Volume: |
25 |
Issue: |
7 |
Pages: |
2632-43 |
|
•
•
•
•
•
|
Publication |
First Author: |
Raval P |
Year: |
1995 |
Journal: |
Gene |
Title: |
Characterization of the 5' flanking region and gene encoding the mouse interferon-gamma receptor. |
Volume: |
154 |
Issue: |
2 |
Pages: |
219-23 |
|
•
•
•
•
•
|
Publication |
First Author: |
Pitulescu ME |
Year: |
2009 |
Journal: |
BMC Biochem |
Title: |
TIPT2 and geminin interact with basal transcription factors to synergize in transcriptional regulation. |
Volume: |
10 |
|
Pages: |
16 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ozawa T |
Year: |
2014 |
Journal: |
Cancer Cell |
Title: |
Most human non-GCIMP glioblastoma subtypes evolve from a common proneural-like precursor glioma. |
Volume: |
26 |
Issue: |
2 |
Pages: |
288-300 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhao Z |
Year: |
2015 |
Journal: |
Nat Genet |
Title: |
Cooperative loss of RAS feedback regulation drives myeloid leukemogenesis. |
Volume: |
47 |
Issue: |
5 |
Pages: |
539-43 |
|
•
•
•
•
•
|
Publication |
First Author: |
Legius E |
Year: |
1992 |
Journal: |
Genomics |
Title: |
NF1-related locus on chromosome 15. |
Volume: |
13 |
Issue: |
4 |
Pages: |
1316-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Le LQ |
Year: |
2007 |
Journal: |
Oncogene |
Title: |
Tumor microenvironment and neurofibromatosis type I: connecting the GAPs. |
Volume: |
26 |
Issue: |
32 |
Pages: |
4609-16 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hambardzumyan D |
Year: |
2011 |
Journal: |
Glia |
Title: |
Genetic modeling of gliomas in mice: new tools to tackle old problems. |
Volume: |
59 |
Issue: |
8 |
Pages: |
1155-68 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gutmann DH |
Year: |
2012 |
Journal: |
J Neurosci |
Title: |
Neurofibromatosis type 1: modeling CNS dysfunction. |
Volume: |
32 |
Issue: |
41 |
Pages: |
14087-93 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ward AF |
Year: |
2012 |
Journal: |
Blood |
Title: |
Targeting oncogenic Ras signaling in hematologic malignancies. |
Volume: |
120 |
Issue: |
17 |
Pages: |
3397-406 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wu J |
Year: |
2016 |
Journal: |
Cell Rep |
Title: |
Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation. |
Volume: |
14 |
Issue: |
8 |
Pages: |
1979-90 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lõhmussaar K |
Year: |
2020 |
Journal: |
Nat Commun |
Title: |
Assessing the origin of high-grade serous ovarian cancer using CRISPR-modification of mouse organoids. |
Volume: |
11 |
Issue: |
1 |
Pages: |
2660 |
|
•
•
•
•
•
|
Publication |
First Author: |
Jecrois ES |
Year: |
2021 |
Journal: |
Dev Cell |
Title: |
Treatment during a developmental window prevents NF1-associated optic pathway gliomas by targeting Erk-dependent migrating glial progenitors. |
Volume: |
56 |
Issue: |
20 |
Pages: |
2871-2885.e6 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mo J |
Year: |
2022 |
Journal: |
Oncogene |
Title: |
Neurofibromin and suppression of tumorigenesis: beyond the GAP. |
Volume: |
41 |
Issue: |
9 |
Pages: |
1235-1251 |
|
•
•
•
•
•
|
Publication |
First Author: |
Perrino MR |
Year: |
2024 |
Journal: |
Life Sci Alliance |
Title: |
C5aR plus MEK inhibition durably targets the tumor milieu and reveals tumor cell phagocytosis. |
Volume: |
7 |
Issue: |
5 |
|
|
•
•
•
•
•
|
Strain |
Attribute String: |
congenic, mutant strain, transgenic, targeted mutation |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Nf1/Nf1 Trp53/Trp53 Tg(GFAP-cre)25Mes/? |
Background: |
involves: 129S/SvEv * 129S4/SvJae * FVB/N |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Nf1/Nf1<+> Pten/Pten Tg(Mx1-cre)1Cgn/? |
Background: |
B6.Cg-Tg(Mx1-cre)1Cgn Nf1 Pten |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Kitl/Kitl Nf1/Nf1 |
Background: |
involves: 129 * 129S/SvEv * C3H * C57BL/6 |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Nf1/Nf1 Prss56/Prss56<+> |
Background: |
involves: 129 * C57BL/6 * DBA/2 |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
127
|
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Kikuchi A |
Year: |
1994 |
Journal: |
Mol Cell Biol |
Title: |
ralGDS family members interact with the effector loop of ras p21. |
Volume: |
14 |
Issue: |
11 |
Pages: |
7483-91 |
|
•
•
•
•
•
|
Publication |
First Author: |
Scheepers A |
Year: |
2001 |
Journal: |
Biochem Biophys Res Commun |
Title: |
Mouse GLUT8: genomic organization and regulation of expression in 3T3-L1 adipocytes by glucose. |
Volume: |
288 |
Issue: |
4 |
Pages: |
969-74 |
|
•
•
•
•
•
|
Publication |
First Author: |
Anastasaki C |
Year: |
2022 |
Journal: |
Acta Neuropathol Commun |
Title: |
Human induced pluripotent stem cell engineering establishes a humanized mouse platform for pediatric low-grade glioma modeling. |
Volume: |
10 |
Issue: |
1 |
Pages: |
120 |
|
•
•
•
•
•
|
Publication |
First Author: |
Untch BR |
Year: |
2018 |
Journal: |
Cancer Res |
Title: |
Tipifarnib Inhibits HRAS-Driven Dedifferentiated Thyroid Cancers. |
Volume: |
78 |
Issue: |
16 |
Pages: |
4642-4657 |
|
•
•
•
•
•
|
Publication |
First Author: |
Montero-Conde C |
Year: |
2017 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Transposon mutagenesis identifies chromatin modifiers cooperating with Ras in thyroid tumorigenesis and detects ATXN7 as a cancer gene. |
Volume: |
114 |
Issue: |
25 |
Pages: |
E4951-E4960 |
|
•
•
•
•
•
|
Publication |
First Author: |
Schreiber J |
Year: |
2017 |
Journal: |
Sci Rep |
Title: |
Mechanisms underlying cognitive deficits in a mouse model for Costello Syndrome are distinct from other RASopathy mouse models. |
Volume: |
7 |
Issue: |
1 |
Pages: |
1256 |
|
•
•
•
•
•
|
Publication |
First Author: |
Cui Y |
Year: |
2021 |
Journal: |
Hum Mol Genet |
Title: |
Merlin cooperates with neurofibromin and Spred1 to suppress the Ras-Erk pathway. |
Volume: |
29 |
Issue: |
23 |
Pages: |
3793-3806 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wilson AF |
Year: |
2023 |
Journal: |
Hum Mol Genet |
Title: |
A common single nucleotide variant in the cytokine receptor-like factor-3 (CRLF3) gene causes neuronal deficits in human and mouse cells. |
Volume: |
32 |
Issue: |
24 |
Pages: |
3342-3352 |
|
•
•
•
•
•
|
Publication |
First Author: |
Johansson EM |
Year: |
2003 |
Journal: |
Oncogene |
Title: |
The p53 tumor suppressor gene is regulated in vivo by nuclear factor 1-C2 in the mouse mammary gland during pregnancy. |
Volume: |
22 |
Issue: |
38 |
Pages: |
6061-70 |
|
•
•
•
•
•
|
Publication |
First Author: |
Acar H |
Year: |
2000 |
Journal: |
Cancer Genet Cytogenet |
Title: |
Detection of integrated murine leukemia viruses in a mouse model of acute myeloid leukemia by fluorescence in situ hybridization combined with tyramide signal amplification. |
Volume: |
121 |
Issue: |
1 |
Pages: |
44-51 |
|
•
•
•
•
•
|
Publication |
First Author: |
Singh MV |
Year: |
1998 |
Journal: |
Biochim Biophys Acta |
Title: |
Nuclear factor 1 is essential for the expression of stearoyl-CoA desaturase 1 gene during preadipocyte differentiation. |
Volume: |
1398 |
Issue: |
2 |
Pages: |
148-56 |
|
•
•
•
•
•
|
Publication |
First Author: |
Werner P |
Year: |
1998 |
Journal: |
Anim Genet |
Title: |
RXRA and HSPA5 map to the telomeric end of dog chromosome 9. |
Volume: |
29 |
Issue: |
3 |
Pages: |
220-3 |
|
•
•
•
•
•
|
Publication |
First Author: |
Stemmer-Rachamimov AO |
Year: |
2004 |
Journal: |
Cancer Res |
Title: |
Comparative pathology of nerve sheath tumors in mouse models and humans. |
Volume: |
64 |
Issue: |
10 |
Pages: |
3718-24 |
|
•
•
•
•
•
|
Publication |
First Author: |
Carroll SL |
Year: |
2005 |
Journal: |
J Neuropathol Exp Neurol |
Title: |
Tumor suppressor mutations and growth factor signaling in the pathogenesis of NF1-associated peripheral nerve sheath tumors: II. The role of dysregulated growth factor signaling. |
Volume: |
64 |
Issue: |
1 |
Pages: |
1-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Daginakatte GC |
Year: |
2007 |
Journal: |
Hum Mol Genet |
Title: |
Neurofibromatosis-1 (Nf1) heterozygous brain microglia elaborate paracrine factors that promote Nf1-deficient astrocyte and glioma growth. |
Volume: |
16 |
Issue: |
9 |
Pages: |
1098-112 |
|
•
•
•
•
•
|
Publication |
First Author: |
Caudell D |
Year: |
2010 |
Journal: |
Blood |
Title: |
Retroviral insertional mutagenesis identifies Zeb2 activation as a novel leukemogenic collaborating event in CALM-AF10 transgenic mice. |
Volume: |
115 |
Issue: |
6 |
Pages: |
1194-203 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bae KB |
Year: |
2011 |
Journal: |
Transgenic Res |
Title: |
Overexpression of Jazf1 induces cardiac malformation through the upregulation of pro-apoptotic genes in mice. |
Volume: |
20 |
Issue: |
5 |
Pages: |
1019-31 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chaney KE |
Year: |
2020 |
Journal: |
Cancer Res |
Title: |
Cdkn2a Loss in a Model of Neurofibroma Demonstrates Stepwise Tumor Progression to Atypical Neurofibroma and MPNST. |
Volume: |
80 |
Issue: |
21 |
Pages: |
4720-4730 |
|
•
•
•
•
•
|
Publication |
First Author: |
Li H |
Year: |
2016 |
Journal: |
Oncogene |
Title: |
Runx1 contributes to neurofibromatosis type 1 neurofibroma formation. |
Volume: |
35 |
Issue: |
11 |
Pages: |
1468-74 |
|
•
•
•
•
•
|
Publication |
First Author: |
Miller AH |
Year: |
2022 |
Journal: |
Dis Model Mech |
Title: |
Mechanistic insights from animal models of neurofibromatosis type 1 cognitive impairment. |
Volume: |
15 |
Issue: |
8 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Na Y |
Year: |
2023 |
Journal: |
Oncogene |
Title: |
Runx1/3-driven adaptive endoplasmic reticulum stress pathways contribute to neurofibromagenesis. |
Volume: |
42 |
Issue: |
13 |
Pages: |
1038-1047 |
|
•
•
•
•
•
|
Publication |
First Author: |
Voigt E |
Year: |
2023 |
Journal: |
Int J Mol Sci |
Title: |
FOXM1, MEK, and CDK4/6: New Targets for Malignant Peripheral Nerve Sheath Tumor Therapy. |
Volume: |
24 |
Issue: |
17 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Brockman QR |
Year: |
2023 |
Journal: |
Sci Rep |
Title: |
Discrepancies in indel software resolution with somatic CRISPR/Cas9 tumorigenesis models. |
Volume: |
13 |
Issue: |
1 |
Pages: |
14798 |
|
•
•
•
•
•
|
Publication |
First Author: |
White EE |
Year: |
2024 |
Journal: |
Cancers (Basel) |
Title: |
The NF1+/- Immune Microenvironment: Dueling Roles in Neurofibroma Development and Malignant Transformation. |
Volume: |
16 |
Issue: |
5 |
|
|
•
•
•
•
•
|